Key result
Elevated serum miR-497-5p was an independent predictor of major adverse cardiovascular events during a 6-month follow-up after PCI in patients with ACS.
Why the study?
The study was designed to investigate the diagnostic value of serum miR-497-5p in acute coronary syndrome and its predictive value for major adverse cardiovascular events after percutaneous coronary intervention.
Does serum miR-497-5p level predict the diagnosis of ACS and the occurrence of MACEs after PCI?
Observational (n=192)
Does serum miR-497-5p level predict the diagnosis of ACS and the occurrence of MACEs after PCI?
Answers are grounded in this paper and cite their sources.
Serum miR-497-5p is a potential diagnostic biomarker for ACS and an independent predictor of MACEs at 6 months following PCI.
This study aimed to investigate the diagnostic value of microRNA (miR)-497-5p in acute coronary syndrome (ACS) and its predictive value for the occurrence of adverse major adverse cardiovascular events (MACEs). Real-time quantitative polymerase chain reaction (RT-qPCR) was performed to detect the expression of serum miR-497-5p in 110 ACS patients and 82 controls. And miR-497-5p levels were found to be significantly elevated in the patients (P < 0.001). Pearson correlation coefficient confirmed that miR-497-5p was positively correlated with Gensini scores (r = 0.684). The area under the Receiver-operating characteristic (ROC) curve was 0.861, which significantly identified patients with ACS, and was confirmed by logistic regression (OR = 8.533, 95%CI = 4.113–17.787, P < 0.001). Kaplan-Meier and Cox regression was performed to evaluate the predictive value of miR-497-5p in the occurrence of MACEs during a 6-month follow-up after percutaneous coronary intervention (PCI) in patients with ACS. The results demonstrated that miR-497-5p was an independent predictor of MACEs (HR = 4.773, 95%CI = 1.569–12.036, P = 0.013) and that patients with high level of miR-497-5p were more likely to develop MACEs after PCI (long-rank P = 0.019). Finally, miR-497-5p positively correlated with endothelial proinflammatory and adhesion factors. Our study suggests that serum miR-497-5p is a potential diagnostic marker for ACS and its elevated levels can predict a high risk of MACEs in ACS patients after PCI. And this may be associated with vascular endothelial injury.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted an observational in Acute coronary syndrome (n=192). Elevated serum miR-497-5p vs. Low serum miR-497-5p / Controls was evaluated on Major adverse cardiovascular events (MACEs) (HR 4.773, 95% CI 1.569-12.036, p=0.013). Elevated serum miR-497-5p was an independent predictor of major adverse cardiovascular events during a 6-month follow-up after PCI in patients with ACS.
Synapse has enriched 10 related papers. Consider them for comparative context: